S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ATNM Actinium Pharmaceuticals Inc

1.12

-0.03 (-2.61%)

08 Feb 2025 - Closed

Delayed by 15 minutes

Form ARS - Annual Report to Security Holders

Actinium Pharmaceuticals (AMEX:ATNM)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Actinium Pharmaceuticals Charts.

Actinium Pharmaceuticals (AMEX:ATNM)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Actinium Pharmaceuticals Charts.

Actinium Pharmaceuticals Inc News

Form 8-K - Current report
Thursday 28 November 2024 (2 months ago) • Edgar (US Regulatory)

Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024
Tuesday 19 November 2024 (3 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Saturday 9 November 2024 (3 months ago) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Wednesday 6 November 2024 (3 months ago) • Edgar (US Regulatory)

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
Monday 4 November 2024 (3 months ago) • PR Newswire (US)

Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology
Friday 20 September 2024 (5 months ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 6 August 2024 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 5 August 2024 (6 months ago) • Edgar (US Regulatory)

More Actinium Pharmaceuticals Inc News Articles

Pro Pac Packaging

Basf Tf 0,875% Nv27 Call...

Settle KBW Nasdaq Bank

Brompton Flaherty and Cr...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions